SCHEMBL27364868

SCHEMBL27364868

Cc1ccc(N2CCN(C(=O)C3CN(C)C3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ TSHR P16473 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.55
▸ AKR1C3 P42330 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ MAPT P10636 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ MAPK1 P28482 1/20 0.51
▸ RAB9A P51151 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ CTSB P07858 1/20 0.47
▸ CTSK P43235 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CHRM1 P11229 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27363823 0.87 TDP1 (0.61) SMN1; SMN2TSHRTDP1AKR1C3MAPT
SCHEMBL19187554 0.86 TDP1 (0.73) SMN1; SMN2TSHRTDP1AKR1C3LMNA
SCHEMBL22542070 0.83 ALDH1A1 (0.69) SMN1; SMN2TSHRTDP1AKR1C3LMNA
SCHEMBL22814982 0.82 ALDH1A1 (0.68) SMN1; SMN2TSHRTDP1AKR1C3MAPT
SCHEMBL22814979 0.82 ALDH1A1 (0.68) SMN1; SMN2TSHRTDP1AKR1C3MAPT
SCHEMBL17888466 0.78 ALDH1A1 (0.57) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL14372238 0.78 AKR1C3 (0.73) SMN1; SMN2AKR1C3LMNAMAPTALDH1A1
SCHEMBL22814963 0.77 MAPT (0.65) SMN1; SMN2TSHRTDP1AKR1C3MAPT
SCHEMBL22814983 0.77 MAPT (0.61) SMN1; SMN2TSHRTDP1AKR1C3MAPT
SCHEMBL22814978 0.76 MAPT (0.64) SMN1; SMN2TSHRTDP1AKR1C3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054591-A1 RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-03-14 — — WO disclosed
Send feedback